IN2015DN02907A - - Google Patents

Info

Publication number
IN2015DN02907A
IN2015DN02907A IN2907DEN2015A IN2015DN02907A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A IN 2907DEN2015 A IN2907DEN2015 A IN 2907DEN2015A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A
Authority
IN
India
Prior art keywords
disintegrating
particle composition
tablet
acid
present
Prior art date
Application number
Inventor
Hiramura Takahiro
Ikura Kiyoshi
Ishikawa Sae
Okabayashi Tomohito
Hashikawa Naohiro
Morita Tetsuro
Ikeda Kimiko
Original Assignee
Daicel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daicel Corp filed Critical Daicel Corp
Publication of IN2015DN02907A publication Critical patent/IN2015DN02907A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

The purpose of the present invention is to provide: an orally disintegrating tablet having excellent tablet hardness and disintegrating properties; an orally disintegrating tablet containing the disintegrating particle composition; and others. The present invention relates to: a disintegrating particle composition comprising four components i.e. , a first disintegrant component that comprises an acid -type carboxymethylcellulose, a second disintegrant component that is different from an acid- type carboxymethylcellulose , an excipient that comprises a sugar or a sugar alcohol, and a crystalline cellulose; an orally disintegrating tablet comprising the disintegrating particle composition and a medicinal component; and others.
IN2907DEN2015 2012-09-20 2013-09-13 IN2015DN02907A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012206897 2012-09-20
PCT/JP2013/074823 WO2014046035A1 (en) 2012-09-20 2013-09-13 Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition

Publications (1)

Publication Number Publication Date
IN2015DN02907A true IN2015DN02907A (en) 2015-09-11

Family

ID=50341348

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2907DEN2015 IN2015DN02907A (en) 2012-09-20 2013-09-13

Country Status (8)

Country Link
US (1) US10292934B2 (en)
EP (1) EP2898899B1 (en)
JP (1) JP6230539B2 (en)
KR (1) KR102114487B1 (en)
CN (1) CN104010663B (en)
IN (1) IN2015DN02907A (en)
TW (1) TWI639446B (en)
WO (1) WO2014046035A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102191468B1 (en) * 2013-07-06 2020-12-15 주식회사 다이셀 Ultrafast-disintegrating tablet and method for manufacturing same
US9974738B2 (en) 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
WO2015046219A1 (en) * 2013-09-27 2015-04-02 株式会社ダイセル Intraorally disintegrable tablet comprising disintegrable granular composition
JP2017226600A (en) * 2014-10-16 2017-12-28 株式会社ダイセル Super fast disintegrating tablet
CN106999600B (en) 2014-11-24 2020-11-20 株式会社大赛璐 Disintegrating granule composition comprising crushed lactose or granulated lactose
EP3238712B1 (en) * 2014-12-25 2023-11-01 Daicel Corporation Very rapidly disintegrating tablet, and method for producing same
TWI695722B (en) * 2015-06-29 2020-06-11 日商大賽璐股份有限公司 Solid preparation outer layer composition and easy-to-take solid preparation containing the outer layer composition
ES2607715B1 (en) 2015-10-01 2018-01-17 Solutex Na, Lcc PROCESS FOR THE PREPARATION AND STABILIZATION OF EMULSIONS WITH OMEGA-3 THROUGH ISOMETRIC CRYSTAL NETWORKS OF CELLULOSE DERIVATIVES
CN108463216B (en) * 2016-01-18 2021-12-31 株式会社大赛璐 Orally-retentive disintegrating solid preparation, process for producing the same, and powder composition for use in the process
JP2019156723A (en) * 2018-03-07 2019-09-19 大原薬品工業株式会社 Permeation/swollen type in oral cavity collapse tablet using vehicle excellent in compression mold ability
JP7036856B2 (en) * 2019-03-28 2022-03-15 日本ケミファ株式会社 Orally disintegrating tablet
EP4056638A4 (en) * 2019-11-07 2022-11-30 Asahi Kasei Kabushiki Kaisha Cellulose composition, tablet, and orally disintegrating tablet
WO2021099531A1 (en) 2019-11-22 2021-05-27 Biohorm, S.L. Zonisamide orodispersible tablets

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (en) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd Solid medicinal preparation
JP2000273039A (en) 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd Composition disintegrable in oral cavity
JP2000290172A (en) * 1999-04-09 2000-10-17 Earth Chem Corp Ltd Effervescent tablet
WO2002030400A1 (en) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Solid preparations
JP4284017B2 (en) * 2000-10-06 2009-06-24 武田薬品工業株式会社 Solid preparation
JP4551627B2 (en) 2003-02-28 2010-09-29 東和薬品株式会社 Method for producing orally disintegrating tablets
US20080274178A1 (en) 2005-08-10 2008-11-06 Shionogi & Co., Ltd. Orally Disintegrating Tablet
JP5123517B2 (en) 2005-11-14 2013-01-23 帝人ファーマ株式会社 Ambroxol oral disintegrating tablet
JP5766899B2 (en) * 2007-04-11 2015-08-19 ニプロ株式会社 Oral disintegrant and method for producing the same
JP2008285434A (en) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd Quickly disintegrating tablet in oral cavity
ES2639130T3 (en) 2007-06-06 2017-10-25 Basf Se Pharmaceutical formulation for the manufacture of rapidly disintegrating tablets
EP2251005B1 (en) * 2008-02-13 2012-10-10 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
JP4920798B2 (en) * 2009-08-11 2012-04-18 大日本住友製薬株式会社 Intraoral quick disintegrating tablet containing two or more kinds of particles
JP5674666B2 (en) 2009-08-11 2015-02-25 富士化学工業株式会社 Disintegrating particle composition and intraoral quick disintegrating tablet
US20110150989A1 (en) 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP6073543B2 (en) 2010-07-08 2017-02-01 沢井製薬株式会社 Method for producing loratadine-containing orally disintegrating tablet
JP6245677B2 (en) * 2012-01-20 2017-12-13 ニプロ株式会社 Orally disintegrating tablets
EP2832350B1 (en) 2012-03-29 2019-07-17 Daicel Corporation Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose

Also Published As

Publication number Publication date
US20150238424A1 (en) 2015-08-27
TWI639446B (en) 2018-11-01
KR102114487B1 (en) 2020-05-22
EP2898899B1 (en) 2019-09-11
KR20150056636A (en) 2015-05-26
US10292934B2 (en) 2019-05-21
CN104010663A (en) 2014-08-27
EP2898899A4 (en) 2016-03-16
JPWO2014046035A1 (en) 2016-08-18
EP2898899A1 (en) 2015-07-29
CN104010663B (en) 2021-02-19
JP6230539B2 (en) 2017-11-15
TW201417843A (en) 2014-05-16
WO2014046035A1 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
IN2015DN02907A (en)
EA033343B1 (en) Compounds inhibiting rip2 kinase, pharmaceutical composition based thereon and use thereof for the treatment of diseases mediated by rip2 kinase
PH12015501385A1 (en) Autotaxin inhibitors
IN2015DN01156A (en)
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
EP4036240A3 (en) Transduction buffer
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
UA109661C2 (en) Pharmaceutical compositions comprising co-crystals of tramadol and celecoxib
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
TN2012000534A1 (en) Pyrazole compounds as sigma receptor inhibitors
MX2016000794A (en) High potency pancreatin pharmaceutical compositions.
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
WO2011048563A3 (en) Orally disintegrating tablets of betahistine
WO2011104652A3 (en) Veterinary compositions
TN2012000507A1 (en) Enteric tablet
IN2013MU03583A (en)
MX2016000480A (en) High potency pancreatin pharmaceutical compositions.
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
CA2890042C (en) 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
IN2014DN03010A (en)
IN2015DN02296A (en)
SI2293791T1 (en) Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
WO2014122671A3 (en) Solid oral compositions of saxagliptin